| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1086284884 |
| P356 | DOI | 10.1186/S13195-017-0273-7 |
| P932 | PMC publication ID | 5488423 |
| P698 | PubMed publication ID | 28655344 |
| P2093 | author name string | Khalid Iqbal | |
| Narjes Baazaoui | |||
| P2860 | cites work | 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders | Q21999335 |
| A Synthetic 7,8-Dihydroxyflavone Derivative Promotes Neurogenesis and Exhibits Potent Antidepressant Effect | Q28298196 | ||
| Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
| Place navigation impaired in rats with hippocampal lesions | Q29547869 | ||
| Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. | Q33359590 | ||
| Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents | Q34111160 | ||
| Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure | Q34361648 | ||
| 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice | Q34373618 | ||
| Failure of neuronal maturation in Alzheimer disease dentate gyrus | Q35327913 | ||
| Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease | Q35745700 | ||
| Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer's Rodent Models | Q36158803 | ||
| Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. | Q36568086 | ||
| Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice | Q36687751 | ||
| Neotic preferences in laboratory rodents: issues, assessment and substrates | Q36697105 | ||
| Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice | Q37372709 | ||
| The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits | Q37972740 | ||
| Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction | Q39990547 | ||
| An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide | Q41866952 | ||
| Beneficial Effect of a CNTF Tetrapeptide on Adult Hippocampal Neurogenesis, Neuronal Plasticity, and Spatial Memory in Mice | Q42478450 | ||
| Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice | Q42989221 | ||
| Basic fibroblast growth factor in Alzheimer's disease | Q43819151 | ||
| Progressive reduction of synaptophysin message in single neurons in Alzheimer disease | Q44003364 | ||
| One-trial memory for object-place associations after separate lesions of hippocampus and posterior parahippocampal region in the monkey. | Q44357380 | ||
| Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease | Q45172855 | ||
| Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound | Q47800596 | ||
| Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice | Q48094578 | ||
| Episodic-like memory is sensitive to both Alzheimer's-like pathological accumulation and normal ageing processes in mice. | Q48122673 | ||
| Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease | Q48299133 | ||
| Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study | Q48437440 | ||
| Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide | Q48454436 | ||
| Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia | Q48461292 | ||
| Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis | Q48465674 | ||
| Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment | Q48493675 | ||
| Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease | Q48646591 | ||
| Reactive synaptogenesis in aging and Alzheimer's disease: lessons learned in the Cotman laboratory | Q48681090 | ||
| Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. | Q48932825 | ||
| Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. | Q50672693 | ||
| Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome. | Q50983125 | ||
| Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. | Q51702049 | ||
| Region-Specific Neurotrophin Imbalances in Alzheimer Disease | Q57833020 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cognitive dysfunction | Q57859955 |
| P304 | page(s) | 45 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Alzheimers Research & Therapy | Q15716761 |
| P1476 | title | Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound | |
| P478 | volume | 9 |
| Q52644594 | A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation. |
| Q47119516 | Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins. |
| Q91706978 | Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice |
| Q64236162 | Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF |
| Q90042419 | Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease |
| Q55714581 | Synaptic aging disrupts synaptic morphology and function in cerebellar Purkinje cells. |
Search more.